FDA authorization under an IND permits first-in-human phase I/II testing of SVT-001 in familial drusen, focusing on safety ...
Morning Overview on MSN
Next-gen psilocybin therapy promises healing without hallucinations
Researchers are now testing whether psilocybin can treat severe depression without producing the hallucinogenic trip that has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results